Lisa Yankie - Mar 3, 2023 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
Sr VP & Chief HR Officer
Signature
Dane Baumgardner, Attorney-In-Fact for Lisa Yankie
Stock symbol
XRAY
Transactions as of
Mar 3, 2023
Transactions value $
-$38,972
Form type
4
Date filed
3/7/2023, 02:54 PM
Previous filing
Jan 17, 2023
Next filing
Apr 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +4.68K +5.49% $0.00 90K Mar 3, 2023 Direct F1
transaction XRAY Common Stock Tax liability -$39K -1.01K -1.12% $38.74 88.9K Mar 3, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Stock Option (Right to Buy) Award $0 +14.4K $0.00 14.4K Mar 3, 2023 Common Stock 14.4K $38.74 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending March 3, 2026.
F2 Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units plus dividend equivalent rights, each as previously reported in Table I.
F3 Stock Options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2026.